192 related articles for article (PubMed ID: 1767349)
1. [Evaluation of misoprostol's clinical utility for gastric/duodenal ulcers seen under long-term use of non-steroidal anti-inflammatory drugs (NSAID)--I. Evaluation of mucosal prophylactic effects by a placebo-controlled double blind comparative study].
Shiokawa Y; Nobunaga M; Saito T; Sakita T; Miwa T; Nakamura K; Gunji A; Aoki K
Ryumachi; 1991 Oct; 31(5):554-71. PubMed ID: 1767349
[No Abstract] [Full Text] [Related]
2. [Evaluation of misoprostol's clinical utility for gastric/duodenal ulcers seen under long-term use of non-steroidal anti-inflammatory drugs (NSAID)--II. Evaluation of therapeutic effects on ulcers under continuous use of NSAID].
Shiokawa Y; Nobunaga M; Saito T; Sakita T; Miwa T; Nakamura K; Gunji A; Aoki K
Ryumachi; 1991 Oct; 31(5):572-82. PubMed ID: 1767350
[No Abstract] [Full Text] [Related]
3. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
4. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
[TBL] [Abstract][Full Text] [Related]
5. Misoprostol and NSAID ulcers.
Isaacs P
Am J Gastroenterol; 1996 Feb; 91(2):187-8. PubMed ID: 8607480
[No Abstract] [Full Text] [Related]
6. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
Koch M; Dezi A; Ferrario F; Capurso I
Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239
[TBL] [Abstract][Full Text] [Related]
7. NSAIDs: a pain in the gut.
Abraham P; Bhatia SJ
J Assoc Physicians India; 1991 Dec; 39(12):915-7. PubMed ID: 1816215
[No Abstract] [Full Text] [Related]
8. Prevention of NSAID-gastropathy.
Ardizzone S; Bianchi Porro G
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
[TBL] [Abstract][Full Text] [Related]
9. NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.
Mohamed AH; Salena BJ; Hunt RH
J Gastroenterol; 1994 Jul; 29 Suppl 7():34-8. PubMed ID: 7921152
[TBL] [Abstract][Full Text] [Related]
10. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
11. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
Dajani EZ; Agrawal NM
Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
Koch M
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
14. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
[TBL] [Abstract][Full Text] [Related]
15. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
Delmas PD; Lambert R; Capron MH
Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500
[TBL] [Abstract][Full Text] [Related]
16. [Present position in the prevention and therapy of NSAID-induced ulcers].
Lehmann FS; Beglinger C
Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
18. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs.
Agrawal NM; Aziz K
J Rheumatol Suppl; 1998 May; 51():17-20. PubMed ID: 9596550
[TBL] [Abstract][Full Text] [Related]
19. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG
J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
[TBL] [Abstract][Full Text] [Related]
20. Prevention of gastroduodenal injury induced by NSAIDs with low-dose misoprostol.
Medina Santillán R; Reyes García G; Mateos García E
Proc West Pharmacol Soc; 1999; 42():33-4. PubMed ID: 10697681
[No Abstract] [Full Text] [Related]
[Next] [New Search]
